论文信息 - 18F-FluorThanatrace (18F-FTT) positron emission tomography (PET/CT) in prostate cancer measures in vivo PARP-1 expression and is associated with adverse clinicopathologic features. - 字舞流文

18F-FluorThanatrace (18F-FTT) positron emission tomography (PET/CT) in prostate cancer measures in vivo PARP-1 expression and is associated with adverse clinicopathologic features.

R. Mach | D. Pryma | E. Schubert | N. Taunk | L. Schwartz | A. Pantel | Mehran Makvandi | S. Carlin | David Lee | Shaan Sadiq | Sina Bhageri | Ciera Mangone | Christina Dulal